The Technical Analyst
NutraLife BioSciences, [NLBS]
Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
NutraLife BioSciences, Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0001
America/New_York / 1 mar 2024 @ 13:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0177 mill |
| EPS: | -0.0200 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 176.62 mill |
| Avg Daily Volume: | 0.0000 mill |
| RATING 2024-03-01 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | n/a | n/a | |||
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2018-10-12 | Ward Edgar | Sell | 25 000 | Common Stock |
| 2018-10-15 | Ward Edgar | Sell | 20 000 | Common Stock |
| 2018-10-15 | Ward Edgar | Sell | 15 000 | Common Stock |
| 2018-10-16 | Ward Edgar | Sell | 50 000 | Common Stock |
| 2018-10-17 | Ward Edgar | Sell | 19 000 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 55 transactions |
| Buy: 64 000 | Sell: 1 008 686 |
Forecast: